1

Technetium Tc 99m tilmanocept fails to detect sentinel lymph nodes in endometrial cancer

nuemtmnaayh4s
Background: Technetium Tc 99m tilmanocept is a synthetic radiotracer specifically designed for sentinel lymph node (SLN) mapping that has been FDA-approved in breast cancer. melanoma. and head and neck cancer. No published studies exist for the use of this radiotracer in endometrial cancer. https://www.lodiceelpueblo.com/product-category/body-gift-sets/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story